New study links fate of personal care products to environmental pollution and human health concernsMay 19, 2008Parental concerns in maintaining germ-free homes for their children have led to an ever-increasing demand and the rapid adoption of anti-bacterial soaps and cleaning agents. But the active ingredients of those antiseptic soaps now have come under scrutiny by the EPA and FDA, due to both environmental and human health concerns. Two closely related antimicrobials, triclosan and triclocarban, are at the center of the debacle. Whereas triclosan (TCS) has long captured the attention of toxicologists due to its structural resemblance to dioxin (the Times Beach and Love Canal poison), triclocarban (TCC) has ski-rocketed in 2004 from an unknown and presumably harmless consumer product additive to one of today's top ten pharmaceuticals and personal care products most frequently found in the environment and in U.S. drinking water resources. Now, Biodesign Institute at Arizona State Univesity researcher Rolf Halden and co-workers, in a feat of environmental detective work, have traced back the active ingredients of soaps - used as long ago as the 1960s - to their current location, the shallow sediments of New York City's Jamaica Bay and the Chesapeake Bay, the nation's largest estuary.
"Our group has shown that antimicrobial ingredients used a half a century ago, by our parents and grandparents, are still present today at parts-per-million concentrations in estuarine sediments underlying the brackish waters into which New York City and Baltimore discharge their treated domestic wastewater," said Halden, a new member of the institute's Center for Environmental Biotechnology. "This extreme environmental persistence by itself is a concern, and it is only amplified by recent studies that show both triclosan and triclocarban to function as endocrine disruptors in mammalian cell cultures and in animal models." Aiding in his team's research was another type of contamination: the radioactive fallout from nuclear testing conducted in the second half of the last century. Using the known deposition history and half-lives of two radioactive isotopes, cesium-137 and beryllium-7, Halden and his collaborators Steven Chillrud, Jerry Ritchie and Richard Bopp were able to assign the approximate time at which sediments observed to contain antimicrobial residues had been deposited in the two East Coast locations. By analyzing vertical cores of sediment deposited over time in the two sampling locations on the East Coast, they showed that TCC, and to a lesser extent, TCS, can persist in estuary sediments. TCC was shown to be present at parts per million levels, which could represent unhealthy levels for aquatic life, especially the bottom feeders that are important to commercial fishing industries like shellfish and crabs. In the Chesapeake Bay samples, the group noticed a significant drop in TCC levels that corresponded to a technology upgrade in the nearby wastewater treatment plant back in 1978. However, earlier work by the team had shown that enhanced removal of TCC and TCS in wastewater treatment plants leads to accumulation of the problematic antimicrobial substances in municipal sludge that often is applied on agricultural land for disposal. Lead author Todd Miller concludes that "little is actually degraded during wastewater treatment and more information is needed regarding the long term consequences these chemicals may have on environmentally beneficial microorganisms." Along the way of studying the deposition history of antimicrobials in sediments, the team also discovered a new pathway for the breakdown of antimicrobial additives of consumer products. Deep in the muddy sediments of the Chesapeake Bay, they found evidence for the activity of anaerobic microorganisms that assist in the decontamination of their habitat by pulling chlorine atoms one by one off the carbon backbone of triclocarban, presumably while obtaining energy for their metabolism in the process. "This is good news," said Halden, "but unfortunately the process does not occur in all locations and furthermore it is quite slow. If we continue to use persistent antimicrobial compounds at the current rate, we are outpacing nature's ability to decompose these problematic compounds." While combining bioenergy production and pollutant destruction has its own appeal, Halden sees a simpler solution to combating the pollution his team discovered: limit the use of antimicrobial personal care products to situations where they improve public health and save lives. "The irony is that these compounds have no measurable benefit over the use of regular soap and water for hand washing; the contact time simply is too short." Unfortunately this cannot be said for the bottom-dwelling organisms in the sampling locations on the East Coast. "Here," Halden concludes, "the affected organisms are experiencing multi-generational, life-time exposures to our chemical follies." Halden is planning to continue his research on persistent antimicrobials by studying their body burden and associated health effects in susceptible populations including mothers and their babies. Arizona State University Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Ebola Vascular Disease Anthrax Methylmercury X-ray Hiv-infected Graphene Nanowire Drug Delivery Aggressive Behavior Postpartum Depression Leukemia Suicidal Behavior Fossil Yeast Cells Gold Nanoparticles Tumor Suppressor Pancreatic Cancer Lung Injury HIV prevention Liquid Crystal Cervical Cancer Brain Tumor Diamond Testicular Cancer
See More: Science News Tags | |||||||||||||||||||||
|
Related Antimicrobial Current Events and Antimicrobial News Articles Singapore nanotechnology combats fatal brain infections Doctors may get a new arsenal for meningitis treatment and the war on drug-resistant bacteria and fungal infections with novel peptide nanoparticles developed by scientists at the Institute of Bioengineering and Nanotechnology (IBN) of Singapore and reported in Nature Nanotechnology. Study Characterizes Eczema Patients Most at Risk for Dangerous Viral Infections Eczema patients at risk for serious viral infections have more severe disease, are more likely to be allergic to food and other allergens, and have a frequent history of staph infections. Plant Microbe Shares Features with Drug-Resistant Pathogen An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. Estrogen Linked to Lowered Immunity in Fish Exposure to estrogen reduces production of immune-related proteins in fish. This suggests that certain compounds, known as endocrine disruptors, may make fish more susceptible to disease. Promising antimicrobial attacks virus, stimulates immune system A promising antimicrobial agent already known to kill bacteria can also kill viruses and stimulate the innate immune system, according to researchers at National Jewish Health. Newly discovered reactions from an old drug may lead to new antibiotics A mineral found at health food stores could be the key to developing a new line of antibiotics for bacteria that commonly cause diarrhea, tooth decay and, in some severe cases, death. Antibiotic resistant bacteria found in fertilizer Vancomycin resistant enterococci (VRE) have been found in sewage sludge, a by-product of waste-water treatment frequently used as a fertilizer. Low levels of vitamin D linked to common vaginal infection in pregnant women Pregnant women with low levels of vitamin D may be more likely to suffer from bacterial vaginosis (BV) - a common vaginal infection that increases a woman's risk for preterm delivery. Nanotechnology holds promise for STD drug delivery Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). New technology shows promise against resistant staph infections Scientists at Albert Einstein College of Medicine of Yeshiva University have combined their revolutionary new drug-delivery system with a powerful antimicrobial agent to treat potentially deadly drug-resistant staph infections in mice. More Antimicrobial Current Events and Antimicrobial News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||